LIMINAL BIOSCIENCES
Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.
LIMINAL BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical
Founded:
1992-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.liminalbiosciences.com
Total Employee:
251+
Status:
Active
Contact:
1(450)781-0115
Email Addresses:
[email protected]
Total Funding:
147.81 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Nginx Euro Amazon Google Maps COVID-19 Amazon Virginia Region DigiCert SSL IIS 10
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-17 | Fairhaven Pharmaceuticals | Fairhaven Pharmaceuticals acquired by Liminal BioSciences | 8 M USD |
| 2016-08-24 | Telesta Therapeutics | Telesta Therapeutics acquired by Liminal BioSciences | N/A |
| 2008-09-04 | Pathogen Removal and Diagnostic Technologies | Pathogen Removal and Diagnostic Technologies acquired by Liminal BioSciences | N/A |
Investors List
National Bank Financial
National Bank Financial investment in Private Equity Round - Liminal BioSciences
Beacon Securities
Beacon Securities investment in Private Equity Round - Liminal BioSciences
Scotiabank
Scotiabank investment in Private Equity Round - Liminal BioSciences
RBC Capital Markets
RBC Capital Markets investment in Private Equity Round - Liminal BioSciences
Paradigm Capital
Paradigm Capital investment in Private Equity Round - Liminal BioSciences
CIBC World Markets
CIBC World Markets investment in Private Equity Round - Liminal BioSciences
Canaccord Genuity Group
Canaccord Genuity Group investment in Private Equity Round - Liminal BioSciences
Jefferies
Jefferies investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Equity - Liminal BioSciences
Newest Events participated
Participated in BioProduction Congress 2017
on 2017-10-17 as exhibitor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as exhibitor
Official Site Inspections
http://www.liminalbiosciences.com Semrush global rank: 6.9 M Semrush visits lastest month: 705
- Host name: ip253.ip-54-38-212.eu
- IP address: 54.38.212.253
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
